Santos JM, Mauro Oscar Grossmann MOG. Systematic review: cost-benefit of Dapagliflozin versusSacubitril/Valsartan in HFrEF. Interamerican Journal of Health Sciences [Internet]. 2023 Apr. 16 [cited 2024 Sep. 19];3:149. Available from: https://ijhsc.uai.edu.ar/index.php/ijhsc/article/view/45